Targeting angiogenic growth factors using therapeutic glycosaminoglycans on doppel-expressing endothelial cells for blocking angiogenic signaling in cancer
Biomaterials, Volume 283, April 2022, 121423 | https://doi.org/10.1016/j.biomaterials.2022.121423
Caspase-cleavable peptide-doxorubicin conjugate in combination with CD47-antagonizing nanocage therapeutics for immune-mediated elimination of colorectal cancer
Biomaterials, Volume 277, October 2021, 121105 | https://doi.org/10.1016/j.biomaterials.2021.121105